Diamyd Medical Financials
| DMN Stock | EUR 1.07 0.01 0.94% |
Diamyd |
Understanding current and past Diamyd Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Diamyd Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Diamyd Medical's assets may result in an increase in income on the income statement.
Diamyd Medical Stock Summary
Diamyd Medical competes with Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, and NorAm Drilling. Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. DIAMYD MEDICAL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | SE0005162880 |
| Business Address | Kungsgatan 29, Stockholm, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.diamyd.com |
| Phone | 46 86 61 00 26 |
| Currency | EUR - Euro |
You should never invest in Diamyd Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Diamyd Stock, because this is throwing your money away. Analyzing the key information contained in Diamyd Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Diamyd Medical Key Financial Ratios
There are many critical financial ratios that Diamyd Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Diamyd Medical AB reports annually and quarterly.Diamyd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diamyd Medical's current stock value. Our valuation model uses many indicators to compare Diamyd Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diamyd Medical competition to find correlations between indicators driving Diamyd Medical's intrinsic value. More Info.Diamyd Medical AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diamyd Medical's earnings, one of the primary drivers of an investment's value.Diamyd Medical AB Systematic Risk
Diamyd Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Diamyd Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Diamyd Medical AB correlated with the market. If Beta is less than 0 Diamyd Medical generally moves in the opposite direction as compared to the market. If Diamyd Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Diamyd Medical AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Diamyd Medical is generally in the same direction as the market. If Beta > 1 Diamyd Medical moves generally in the same direction as, but more than the movement of the benchmark.
Diamyd Medical Thematic Clasifications
Diamyd Medical AB is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Diamyd Medical November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Diamyd Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Diamyd Medical AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Diamyd Medical AB based on widely used predictive technical indicators. In general, we focus on analyzing Diamyd Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Diamyd Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 15.68 | |||
| Value At Risk | (4.04) | |||
| Potential Upside | 5.88 |
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |